Fussen Pharmaceutical (01652): Zhongzheng Tianheng was appointed as the new auditor

Zhitongcaijing · 2d ago

According to Zhitong Finance App, Fuson Pharmaceuticals (01652) issued an announcement. Since the board of directors and KPMG (KPMG) failed to reach a consensus on the recommended review fees for the Group's consolidated financial statements for the financial year ending December 31, 2025, KPMG has resigned as the company's auditor with effect from December 24, 2025.

On the recommendation of the Audit Committee, Zhongzheng Tianheng Certified Public Accountants Co., Ltd. (Zhongzheng Tianheng) was appointed as the Company's new auditor to fill the temporary vacancy after KPMG left office. The term of office will run until the end of the next Annual General Meeting of Shareholders of the Company.